H. Bryan Brewer

24.8k citations

239 papers · 19.2k indexed · 5 hit papers · h-index 72

Impact in

Endocrinology, Diabetes and Metabolism top 0.05%
- Diabetes, Cardiovascular Risks, and Lipoproteins
Surgery top 0.05%
- Cholesterol and Lipid Metabolism
- Lipoproteins and Cardiovascular Health

Papers in

Endocrinology, Diabetes and Metabolism 91
- Diabetes, Cardiovascular Risks, and Lipoproteins 83
Surgery 125
- Lipoproteins and Cardiovascular Health 80
- Cholesterol and Lipid Metabolism 60

Co-authors: Silvia Santamarina-Fojo Ernst J. Schaefer Richard E. Gregg Alan T. Remaley Loren A. Zech Rosemary Ronan Gerd Assmann S W Law
Journals: Journal of Biological Chemistry (36 papers)Journal of Lipid Research (27 papers)Journal of Clinical Investigation (22 papers)Proceedings of the National Academy of Sciences (22 papers)Biochemical and Biophysical Research Communications (15 papers)
Partner nations: United States France Australia

In The Last Decade

H. Bryan Brewer

239 papers receiving 18.4k citations

Hit Papers

5 papers align trajectories log scale

Dysfunctional HDL and atherosclerotic cardiovascular disease 2015 · 567 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2015 Nature Reviews Cardiology
2012 Circulation
2011 Clinical Chemistry
1999 Nature Genetics
1994 Nature

Peers

Countries citing papers authored by H. Bryan Brewer

Since Specialization

Citations

This map shows the geographic impact of H. Bryan Brewer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Bryan Brewer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Bryan Brewer more than expected).

Fields of papers citing papers by H. Bryan Brewer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. Bryan Brewer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Bryan Brewer. The network helps show where H. Bryan Brewer may publish in the future.

Co-authorship network

The 25 scholars most cited alongside H. Bryan Brewer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with H. Bryan Brewer Line = papers co-authored together H. Bryan Brewer links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Evacetrapib and Cardiovascular Outcomes in High-Risk Vascular Disease Journal of Vascular Surgery ·A. Michael Lincoff, Stephen J. Nicholls, Jeffrey Riesmeyer, P.J. Barter, H. Bryan Brewer, bahmadh	2017	4
2	Cholesterol ester transfer protein inhibition by TA-8995 in patients with mild dyslipidaemia (TULIP): a randomised, double-blind, placebo-controlled phase 2 trial The Lancet ·G. Kees Hovingh, John J.P. Kastelein, Sander J. H. van Deventer, Patrick Round, J. Ford, Danish Saleheen, Daniel J. Rader, H. Bryan Brewer, Philip J. Barter	2015	176
3	Asymmetry in the Lipid Affinity of Bihelical Amphipathic Peptides Journal of Biological Chemistry ·Amar A Sethi, John A. Stonik, Thomas Fairwell, Steve J. Demosky, Marcelo Amar, Edward B. Neufeld, H. Bryan Brewer, W. Sean Davidson, Wilissa D’Souza, Dmitri Sviridov, Alan T. Remaley	2008	77
4	Human Lecithin:Cholesterol Acyltransferase Deficiency Arteriosclerosis Thrombosis and Vascular Biology ·Masato Nishiwaki, Katsunori Ikewaki, Giovanni Bader, Hassan Nazih, Minna L. Hannuksela, Alan T. Remaley, Robert D. Shamburek, H. Bryan Brewer	2006	20
5	The orphan nuclear receptor LRH-1 activates the ABCG5/ABCG8 intergenic promoter Journal of Lipid Research ·Lita A. Freeman, Arion Kennedy, Justina E. Wu, Elise Salleo, Alan T. Remaley, Silvia Santamarina-Fojo, H. Bryan Brewer	2004	82
6	Synthetic amphipathic helical peptides promote lipid efflux from cells by an ABCA1-dependent and an ABCA1-independent pathway Journal of Lipid Research ·Alan T. Remaley, Thomas Fairwell, John A. Stonik, Steve J. Demosky, Elise Salleo, Edward B. Neufeld, Alexander V. Bocharov, Tatyana G. Vishnyakova, Amy P. Patterson, Thomas L. Eggerman, Silvia Santamarina-Fojo, H. Bryan Brewer	2003	166
7	Cellular Localization and Trafficking of the Human ABCA1 Transporter Journal of Biological Chemistry ·Edward B. Neufeld, Alan T. Remaley, Stephen J. Demosky, John A. Stonik, Adele Cooney, Marion E. Sparks, Nancy K. Dwyer, Mei Zhang, Joan Blanchette‐Mackie, Silvia Santamarina-Fojo, H. Bryan Brewer	2001	275
8	ABCA1 overexpression leads to hyperalphalipoproteinemia and increased biliary cholesterol excretion in transgenic mice Journal of Clinical Investigation ·Boris Vaisman, Gilles Lambert, Marcelo Amar, Charles Joyce, Toshimitsu Ito, Robert D. Shamburek, William J. Cain, Jamila Fruchart‐Najib, Rosanna Renee Bether, Alan T. Remaley, H. Bryan Brewer, Silvia Santamarina-Fojo	2001	190
9	Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1 Nature Genetics ·Stephan Rust, Marie Rosier, Harald Funke, José Manuel Fernández‐Real, Zahir Amoura, Jean‐Charles Piette, Jean‐François Deleuze, H. Bryan Brewer, Nicolas Duverger, Patrice Denèfle, Gerd Assmann Hit paper breakdown →	1999	1189
10	Hyperalphalipoproteinemia in human lecithin cholesterol acyltransferase transgenic rabbits. In vivo apolipoprotein A-I catabolism is delayed in a gene dose-dependent manner. Journal of Clinical Investigation ·Обатнин Виктор Алексеевич, Silvia Santamarina-Fojo, L A Zech, Annie M. Bérard, Boris Vaisman, Susan M. Meyn, D. Powell, H. Bryan Brewer, J M Hoeg	1996	38
11	A Naturally Occurring Mutation at the Second Base of Codon Asparagine 43 in the Proposed N-Linked Glycosylation Site of Human Lipoprotein Lipase: In Vivo Evidence That Asparagine 43 Is Essential for Catalysis and Secretion Biochemical and Biophysical Research Communications ·Junji Kobayashi, Hidekuni Inadera, Yuki Fujita, Glenda D. Talley, Naoko Morisaki, Sayaka Yoshida, Y Saito, S S Fojo, H. Bryan Brewer	1994	11
12	Human apolipoprotein mutants III : diagnosis and treatment Springer eBooks ·Cesare R. Sirtori, Guido Franceschini, H. Bryan Brewer	1993	2
13	Very low high-density lipoproteins without coronary atherosclerosis The Lancet ·D J Rader, Katsunori Ikewaki, Nicolas Duverger, Irwin M. Feuerstein, H. Bryan Brewer, W E Connor	1993	51
14	Heterozygous apolipoprotein C‐II deficiency: lipoprotein and apoprotein phenotype and Rsal restriction enzyme polymorphism in the Apo C'IIPadova kindred European Journal of Clinical Investigation ·Carlo Gabelli, Claudio Bilato, Silvia Santamarina-Fojo, S. Martini, H. Bryan Brewer, Gaetano Crepaldi, Giovannella Baggio	1993	10
15	Fish eye syndrome: a molecular defect in the lecithin-cholesterol acyltransferase (LCAT) gene associated with normal alpha-LCAT-specific activity. Implications for classification and prognosis. Journal of Clinical Investigation ·Hanns‐Georg Klein, Silvia Santamarina-Fojo, Nicolas Duverger, Michel Clerc, M.F. Dumon, J J Albers, Santica M. Marcovina, H. Bryan Brewer	1993	54
16	Two different allelic mutations in the lecithin-cholesterol acyltransferase gene associated with the fish eye syndrome. Lecithin-cholesterol acyltransferase (Thr123----Ile) and lecithin-cholesterol acyltransferase (Thr347----Met). Journal of Clinical Investigation ·Hanns‐Georg Klein, P Lohse, P. Haydn Pritchard, D Bojanovski, (unknown), H. Bryan Brewer	1992	50
17	Apolipoprotein E-1Harrisburg: a new variant of apolipoprotein E dominantly associated with type III hyperlipoproteinemia Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism ·W. Alexander Mann, Richard E. Gregg, Dennis L. Sprecher, H. Bryan Brewer	1989	61
18	Semi-automated enzyme-linked immunosorbent assay (ELISA) for the quantification of apolipoprotein B using monoclonal antibodies Clinica Chimica Acta ·Casiano Del Ángel Mosqueda, Richard E. Gregg, WANG Qianqian, SUN Yue, LONG Ruixue, WU Zeyu, JIANG Li, ZHAO Jiansheng, ZHANG Hao, XU Baocai, XU Feiran, H. Bryan Brewer	1987	25
19	Identification of a novel in-frame translational stop codon in human intestine ApoB mRNA Biochemical and Biophysical Research Communications ·Ashok Hospattankar, Keiichi Higuchi, S W Law, M. Cozzari, H. Bryan Brewer	1987	68
20	Familial apolipoprotein E deficiency. Journal of Clinical Investigation ·Ernst J. Schaefer, Richard E. Gregg, Giancarlo Ghiselli, Trudy M. Forte, José M. Ordovás, Loren A. Zech, H. Bryan Brewer	1986	254

About H. Bryan Brewer

H. Bryan Brewer is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery, Biochemistry, Cancer Research and Cardiology and Cardiovascular Medicine, having authored 239 papers that have together received 19.2k indexed citations. Recurring topics across this work include Diabetes, Cardiovascular Risks, and Lipoproteins (83 papers), Lipoproteins and Cardiovascular Health (80 papers), Cholesterol and Lipid Metabolism (60 papers), Peroxisome Proliferator-Activated Receptors (45 papers), Lipid metabolism and disorders (36 papers), Cancer, Lipids, and Metabolism (32 papers), Drug Transport and Resistance Mechanisms (23 papers) and Lipid metabolism and biosynthesis (15 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (6.5k citations), Surgery (10.9k citations), Cancer Research (3.5k citations), Biochemistry (1.4k citations) and Oncology (3.4k citations). H. Bryan Brewer has collaborated with scholars based in United States, France and Australia. Frequent co-authors include Silvia Santamarina-Fojo, Ernst J. Schaefer, Richard E. Gregg, Alan T. Remaley, Loren A. Zech, Rosemary Ronan, Gerd Assmann, S W Law, Robert S. Rosenson and J M Hoeg. Their work appears in journals such as Journal of Biological Chemistry, Journal of Lipid Research, Journal of Clinical Investigation, Proceedings of the National Academy of Sciences and Biochemical and Biophysical Research Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact